A new study by scientists at Nova Southeastern University (NSU) in Florida (USA) shows that poor sleep is linked to poor gut microbiota diversity, which in turns affects overall health.
A recent study, from researchers at University of California-Los Angeles (UCLA), provides further evidence that a correlation exists between the gut microbiota composition and emotional and behavioural responses.
A new meta-analysis of controlled clinical trials shows the antidepressant and anxiolytic potential of probiotics
4 Jun 2019by GMFH Editing Team
To what extent targeting the gut microbiota as a potential treatment for depression and anxiety is unknown. A new systematic review and meta-analysis of 34 controlled clinical trials concludes that probioticsbut not prebioticsmay exert potential antidepressant and anxiolytic effects.
The effects of antidepressants are partly mediated by specific gut bacteria in mice
20 May 2019by Andreu Prados
The gut microbiota community is being explored as a new contributor to drugs metabolism. Human antidepressants have been shown to affect the gut microbiota in mice, with Ruminococcus flavefaciens mediating the antidepressant effect of duloxetine.
Scientists identified two bacteria from gut microbiota linked to mental health
8 May 2019by Cristina Sáez
Researchers at KU Leuven in Belgium have found most human gut bacteria produce neurotransmitters, which are chemicals (e.g. dopamine and serotonin) that let neurons communicate with each other.
A large study of Belgian and Dutch people finds new associations between gut microbes and depression
21 Feb 2019by Andreu Prados
Previous mice experiments and small studies of people with depression have revealed a connection between the gut microbiome in behaviour. A recent study using two large population cohorts has strengthened the link between microbial disturbances, depression and quality of life.
The gut microbiota modifies behavior in mice through affecting metabolism
13 Feb 2019by Karina Kaplun
According to a new study, the microbiome is among the factors that directly influence obesity. Others include environmental causes and genetic predisposition.
Bifidobacterium pseudocatenulatum attenuates obesity-related behavioral changes in mice
14 Jan 2019by Yolanda Sanz
Alterations in the crosstalk between the gastrointestinal tract and the nervous system could play a role in the global obesity pandemic. New findings shed light on the role of the probiotic Bifidobacterium pseudocatenulatum CECT 7765 in restoring behavioral changes found in diet-induced obesity in mice.
A new study shows probiotics can reduce depression scores and alter brain activity in humans with IBS
3 Aug 2017by Andreu Prados
A new study has found that the probiotic Bifidobacterium longum NCC3001 can reduce depression scores and increase quality of life in patients with IBS.
In irritable bowel syndrome, probiotic bacteria show promise for improving mood
5 Jul 2017by Heather Galipeau
A new study shows that a specific probiotic can help treat symptoms of depression in patients who suffer from irritable bowel syndrome (or IBS).
